Tsumura Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Tsumura has been growing earnings at an average annual rate of 5.4%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 4.6% per year. Tsumura's return on equity is 8.2%, and it has net margins of 15%.
Información clave
5.4%
Tasa de crecimiento de los beneficios
5.5%
Tasa de crecimiento del BPA
Crecimiento de la industria Pharmaceuticals | 3.4% |
Tasa de crecimiento de los ingresos | 4.6% |
Rentabilidad financiera | 8.2% |
Margen neto | 15.0% |
Próxima actualización de resultados | 07 Nov 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Tsumura & Co.'s (TSE:4540) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 17Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Sep 26Tsumura & Co.'s (TSE:4540) P/E Still Appears To Be Reasonable
Sep 24Tsumura (TSE:4540) Will Pay A Larger Dividend Than Last Year At ¥68.00
Sep 04Tsumura (TSE:4540) Is Increasing Its Dividend To ¥68.00
Aug 21Tsumura's (TSE:4540) Promising Earnings May Rest On Soft Foundations
Aug 12Tsumura's (TSE:4540) Upcoming Dividend Will Be Larger Than Last Year's
Jul 25Tsumura (TSE:4540) Has Announced That It Will Be Increasing Its Dividend To ¥68.00
Jul 11We Think Tsumura (TSE:4540) Can Stay On Top Of Its Debt
Jun 24News Flash: Analysts Just Made A Sizeable Upgrade To Their Tsumura & Co. (TSE:4540) Forecasts
Mar 28Tsumura (TSE:4540) Will Pay A Dividend Of ¥35.00
Mar 15Earnings Not Telling The Story For Tsumura & Co. (TSE:4540) After Shares Rise 39%
Mar 07Tsumura (TSE:4540) Has Announced A Dividend Of ¥35.00
Feb 26Desglose de ingresos y gastos
Cómo gana y gasta dinero Tsumura. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
---|---|---|---|---|
30 Jun 24 | 157,499 | 23,555 | 49,047 | 0 |
31 Mar 24 | 150,845 | 16,707 | 40,511 | 8,288 |
31 Dec 23 | 148,793 | 16,758 | 40,850 | 7,594 |
30 Sep 23 | 145,238 | 13,598 | 40,852 | 7,594 |
30 Jun 23 | 142,662 | 14,182 | 40,179 | 7,594 |
31 Mar 23 | 140,043 | 16,482 | 39,771 | 7,594 |
31 Dec 22 | 138,240 | 19,322 | 40,057 | 7,313 |
30 Sep 22 | 136,237 | 20,760 | 38,896 | 7,313 |
30 Jun 22 | 132,192 | 20,079 | 38,055 | 7,313 |
31 Mar 22 | 129,546 | 18,836 | 36,775 | 7,313 |
31 Dec 21 | 129,783 | 17,365 | 39,879 | 6,631 |
30 Sep 21 | 130,305 | 17,214 | 43,656 | 6,631 |
30 Jun 21 | 130,886 | 16,676 | 46,567 | 6,631 |
31 Mar 21 | 130,883 | 15,332 | 48,917 | 6,631 |
31 Dec 20 | 127,545 | 15,431 | 48,063 | 6,270 |
30 Sep 20 | 126,440 | 14,811 | 47,493 | 6,270 |
30 Jun 20 | 124,317 | 13,907 | 46,980 | 6,270 |
31 Mar 20 | 123,248 | 13,765 | 47,353 | 6,270 |
31 Dec 19 | 124,081 | 14,552 | 47,565 | 5,926 |
30 Sep 19 | 123,440 | 14,548 | 47,359 | 5,926 |
30 Jun 19 | 121,829 | 14,980 | 47,258 | 5,926 |
31 Mar 19 | 120,906 | 14,593 | 47,009 | 5,926 |
31 Dec 18 | 118,978 | 13,933 | 46,482 | 6,048 |
30 Sep 18 | 117,865 | 14,972 | 46,065 | 6,048 |
30 Jun 18 | 118,587 | 14,826 | 45,712 | 6,048 |
31 Mar 18 | 117,879 | 14,504 | 45,176 | 6,048 |
31 Dec 17 | 117,906 | 13,627 | 44,899 | 6,087 |
30 Sep 17 | 116,877 | 13,791 | 44,088 | 6,087 |
30 Jun 17 | 115,330 | 12,730 | 43,758 | 6,087 |
31 Mar 17 | 114,954 | 12,488 | 43,429 | 6,087 |
31 Dec 16 | 114,022 | 13,079 | 42,456 | 5,968 |
30 Sep 16 | 114,424 | 11,330 | 42,329 | 5,968 |
30 Jun 16 | 114,557 | 12,373 | 42,038 | 5,968 |
31 Mar 16 | 112,625 | 12,557 | 41,775 | 5,968 |
31 Dec 15 | 111,986 | 12,550 | 42,267 | 6,252 |
30 Sep 15 | 112,288 | 14,485 | 42,440 | 6,252 |
30 Jun 15 | 110,570 | 14,206 | 42,694 | 6,252 |
31 Mar 15 | 110,438 | 14,075 | 42,835 | 6,252 |
31 Dec 14 | 112,445 | 15,407 | 42,536 | 5,949 |
30 Sep 14 | 109,369 | 17,109 | 42,499 | 5,949 |
30 Jun 14 | 110,187 | 17,248 | 42,616 | 5,949 |
31 Mar 14 | 110,057 | 18,050 | 42,859 | 5,949 |
31 Dec 13 | 107,821 | 18,023 | 43,756 | 4,904 |
Ingresos de calidad: 4540 has high quality earnings.
Margen de beneficios creciente: 4540's current net profit margins (15%) are higher than last year (9.9%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: 4540's earnings have grown by 5.4% per year over the past 5 years.
Acelerando crecimiento: 4540's earnings growth over the past year (66.1%) exceeds its 5-year average (5.4% per year).
Beneficios vs. Industria: 4540 earnings growth over the past year (66.1%) exceeded the Pharmaceuticals industry 38.7%.
Rentabilidad financiera
Alta ROE: 4540's Return on Equity (8.2%) is considered low.